Literature DB >> 27891695

Downregulation of neuronal vasoactive intestinal polypeptide in Parkinson's disease and chronic constipation.

F Giancola1,2, F Torresan1, R Repossi1, F Bianco1,2, R Latorre1, A Ioannou1, M Guarino3, U Volta1, P Clavenzani2, M Mazzoni2, R Chiocchetti2, F Bazzoli1, R A Travagli4, C Sternini5, R De Giorgio1,6.   

Abstract

BACKGROUND: Chronic constipation (CC) is a common and severe gastrointestinal complaint in Parkinson's disease (PD), but its pathogenesis remains poorly understood. This study evaluated functionally distinct submucosal neurons in relation to colonic motility and anorectal function in PD patients with constipation (PD/CC) vs both CC and controls.
METHODS: Twenty-nine PD/CC and 10 Rome III-defined CC patients were enrolled. Twenty asymptomatic age-sex matched subjects served as controls. Colonic transit time measurement and conventional anorectal manometry were evaluated in PD/CC and CC patients. Colonoscopy was performed in all three groups. Colonic submucosal whole mounts from PD/CC, CC, and controls were processed for immunohistochemistry with antibodies for vasoactive intestinal polypeptide (VIP) and peripheral choline acetyltransferase, markers for functionally distinct submucosal neurons. The mRNA expression of VIP and its receptors were also assessed. KEY
RESULTS: Four subgroups of PD/CC patients were identified: delayed colonic transit plus altered anorectal manometry (65%); delayed colonic transit (13%); altered manometric pattern (13%); and no transit and manometric impairment (9%). There were no differences in the number of neurons/ganglion between PD/CC vs CC or vs controls. A reduced number of submucosal neurons containing VIP immunoreactivity was found in PD/CC vs controls (P<.05). VIP, VIPR1, and VIPR2 mRNA expression was significantly reduced in PD/CC vs CC and controls (P<.05). CONCLUSIONS AND INFERENCES: Colonic motor and rectal sensory functions are impaired in most PD/CC patients. These abnormalities are associated with a decreased VIP expression in submucosal neurons. Both sensory-motor abnormalities and neurally mediated motor and secretory mechanisms are likely to contribute to PD/CC pathophysiology.
© 2016 John Wiley & Sons Ltd.

Entities:  

Keywords:  anorectal manometry; cholinergic neurons; secretomotor neurons; slow transit constipation

Mesh:

Substances:

Year:  2016        PMID: 27891695      PMCID: PMC5393951          DOI: 10.1111/nmo.12995

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  38 in total

Review 1.  Minimum standards of anorectal manometry.

Authors:  S S C Rao; F Azpiroz; N Diamant; P Enck; G Tougas; A Wald
Journal:  Neurogastroenterol Motil       Date:  2002-10       Impact factor: 3.598

2.  Incidence of emergency intestinal pseudo-obstruction in Parkinson's disease.

Authors:  Fuyuki Tateno; Ryuji Sakakibara; Masahiko Kishi; Emina Ogawa; Yasushi Yoshimatsu; Nobuo Takada; Yasuo Suzuki; Takayuki Mouri; Tomoyuki Uchiyama; Tatsuya Yamamoto
Journal:  J Am Geriatr Soc       Date:  2011-12       Impact factor: 5.562

3.  Parkinson's disease: the presence of Lewy bodies in Auerbach's and Meissner's plexuses.

Authors:  K Wakabayashi; H Takahashi; S Takeda; E Ohama; F Ikuta
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

4.  Characterization of swallowing and defecation in Parkinson's disease.

Authors:  L L Edwards; E M Quigley; R K Harned; R Hofman; R F Pfeiffer
Journal:  Am J Gastroenterol       Date:  1994-01       Impact factor: 10.864

5.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

Review 6.  Gastrointestinal dysfunction in Parkinson's disease.

Authors:  Alfonso Fasano; Naomi P Visanji; Louis W C Liu; Antony E Lang; Ronald F Pfeiffer
Journal:  Lancet Neurol       Date:  2015-06       Impact factor: 44.182

Review 7.  Neuroanatomy and pathology of sporadic Parkinson's disease.

Authors:  Heiko Braak; Kelly Del Tredici
Journal:  Adv Anat Embryol Cell Biol       Date:  2009       Impact factor: 1.231

8.  Constipation is reduced by beta-blockers and increased by dopaminergic medications in Parkinson's disease.

Authors:  Gennaro Pagano; Echo E Tan; Janelle M Haider; Alyssa Bautista; Michele Tagliati
Journal:  Parkinsonism Relat Disord       Date:  2014-11-25       Impact factor: 4.891

9.  Colonic transit time and rectoanal videomanometry in Parkinson's disease.

Authors:  R Sakakibara; T Odaka; T Uchiyama; M Asahina; K Yamaguchi; T Yamaguchi; T Yamanishi; T Hattori
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-02       Impact factor: 10.154

10.  Dopaminergic defect of enteric nervous system in Parkinson's disease patients with chronic constipation.

Authors:  C Singaram; W Ashraf; E A Gaumnitz; C Torbey; A Sengupta; R Pfeiffer; E M Quigley
Journal:  Lancet       Date:  1995-09-30       Impact factor: 79.321

View more
  15 in total

1.  Gastrointestinal function in dementia with Lewy bodies: a comparison with Parkinson disease.

Authors:  Hirokazu Doi; Ryuji Sakakibara; Masayuki Masuda; Fuyuki Tateno; Yosuke Aiba; Masahiko Kishi; Tomonori Yamanishi; Tatsuya Yamamoto; Katsuyoshi Matsuoka
Journal:  Clin Auton Res       Date:  2019-02-11       Impact factor: 4.435

Review 2.  Enteric nervous system manifestations of neurodegenerative disease.

Authors:  Alcmène Chalazonitis; Meenakshi Rao
Journal:  Brain Res       Date:  2018-01-31       Impact factor: 3.252

Review 3.  A Critical Analysis of Intestinal Enteric Neuron Loss and Constipation in Parkinson's Disease.

Authors:  Chelsea O'Day; David Isaac Finkelstein; Shanti Diwakarla; Rachel Mai McQuade
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.520

Review 4.  New Understanding on the Pathophysiology and Treatment of Constipation in Parkinson's Disease.

Authors:  Jianli Xu; Lei Wang; Xi Chen; Weidong Le
Journal:  Front Aging Neurosci       Date:  2022-06-22       Impact factor: 5.702

5.  Modulation of the main porcine enteric neuropeptides by a single low-dose of lipopolysaccharide (LPS) Salmonella Enteritidis.

Authors:  Anita Mikołajczyk; Sławomir Gonkowski; Dagmara Złotkowska
Journal:  Gut Pathog       Date:  2017-12-12       Impact factor: 4.181

6.  Rehabilitative Impact of Exercise Training on Human Skeletal Muscle Transcriptional Programs in Parkinson's Disease.

Authors:  Kaleen M Lavin; Yongchao Ge; Stuart C Sealfon; Venugopalan D Nair; Katarzyna Wilk; Jeremy S McAdam; Samuel T Windham; Preeti Lakshman Kumar; Merry-Lynn N McDonald; Marcas M Bamman
Journal:  Front Physiol       Date:  2020-06-17       Impact factor: 4.566

7.  Atrophic Myenteric and Submucosal Neurons Are Observed in Parkinson's Disease.

Authors:  Bodil Ohlsson; Elisabet Englund
Journal:  Parkinsons Dis       Date:  2019-06-19

8.  Enhanced Contractive Tension and Upregulated Muscarinic Receptor 2/3 in Colorectum Contribute to Constipation in 6-Hydroxydopamine-Induced Parkinson's Disease Rats.

Authors:  Xiao-Li Zhang; Xiao-Hui Zhang; Xiao Yu; Li-Fei Zheng; Xiao-Yan Feng; Chen-Zhe Liu; Zhu-Sheng Quan; Yue Zhang; Jin-Xia Zhu
Journal:  Front Aging Neurosci       Date:  2021-12-23       Impact factor: 5.750

Review 9.  TLR2 and TLR4 in Parkinson's disease pathogenesis: the environment takes a toll on the gut.

Authors:  Anastazja M Gorecki; Chidozie C Anyaegbu; Ryan S Anderton
Journal:  Transl Neurodegener       Date:  2021-11-17       Impact factor: 8.014

10.  Characterisation of tau in the human and rodent enteric nervous system under physiological conditions and in tauopathy.

Authors:  Arthur Lionnet; Matthew A Wade; Anne-Gaëlle Corbillé; Alice Prigent; Sébastien Paillusson; Maddalena Tasselli; Jacques Gonzales; Emilie Durieu; Malvyne Rolli-Derkinderen; Emmanuel Coron; Emilie Duchalais; Michel Neunlist; Michael S Perkinton; Diane P Hanger; Wendy Noble; Pascal Derkinderen
Journal:  Acta Neuropathol Commun       Date:  2018-07-23       Impact factor: 7.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.